Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.
  • Company

Company Rank

0

Country Rank

SR Score

0

SR Web

0

SR Social

0

Syntaxin engineers and develops bacterial-based protein therapeutics for the treatment of neurological, inflammatory and endocrine diseases.

Acquired by Ipsen on July 15, 2013

Welcome to the official Facebook page for Ipsen. Learn more at: www.ipsen.com

Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care.

It develops and commercializes innovative medici...
See More

Website: https://www.syntaxin.com

Founded: January 01, 2005

 SR Traffic - Month

 Ahrefs

X

Syntaxin Competitors

Add Competitor

Startup Industry Description
24Genetics
Pharmaceuticals & Biotechnology DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
NarcX
Pharmaceuticals & Biotechnology Be Part of the Solution - NarcX is the only solution that destroys and dispo ...
Turn Biotechnologies
Pharmaceuticals & Biotechnology Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...
View more competitors»

Syntaxin Funding

Add Funding

Date Round Amount Investors
Nov 11, 2010 Series C $ 29,000,000
Oct 31, 2007 Series B $ 32,000,000
Nov 14, 2005 Series A $ 10,390,000
View more funding rounds»

Syntaxin Acquisitions

Add Acquisition

Date Acquired Amount
There are no acquisitions.

Syntaxin Products

Add Product

Product Stage Description
There are no products.

Syntaxin Team

Add Team Member

Person Role Period
Keith Foster
Founder Unknown to Unknown

Syntaxin News

Add News

Date Title
There are no news.

Syntaxin Statistics

Last Week

Rank

SR Score

Likes

Followers



Last Month

Rank

SR Score

Likes

Followers